Form 4 for EVH Evolent Health, Inc.
Accepted 2023-03-07 00:00:00 ET · period of report 2023-03-03 · accession 0001628908-23-000047 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-03-07 | 2023-03-06+ | EVH | Blackley Seth | CEO, Dir | S - Sale+OE | $34.53 | -169.0K | 880.1K | -16% | -$5.84M |
| D | 2023-03-07 | 2023-03-03 | EVH | Blackley Seth | CEO, Dir | M - OptEx | $0.00 | +360.0K | 952.0K | +61% | $0 |
| D | 2023-03-07 | 2023-03-03 | EVH | Blackley Seth | CEO, Dir | M - OptEx | $0.00 | -360.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-03-06 | S | D | 2,012 | $35.01 | 878,066 | D | — | — | (F3) This number represents shares of Class A Common Stock sold to satisfy the tax withholding obligation due upon vesting of LSUs. (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.975 to $35.060, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. (F2) Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. |
| 2 | Common | Class A Common Stock | 2023-03-07 | S | D | 95,055 | $34.62 | 783,011 | D | — | — | (F3) This number represents shares of Class A Common Stock sold to satisfy the tax withholding obligation due upon vesting of LSUs. (F6) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.35 to $34.92, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. (F2) Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. |
| 3 | Common | Class A Common Stock | 2023-03-03 | M | A | 360,000 | $0.00 | 951,994 | D | — | — | (F1) Represents the vesting of the leveraged stock units ("LSUs") granted to Mr. Blackley on March 2, 2020, based on the cumulative performance of the Issuer's Class A Common Stock. (F2) Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. |
| 4 | Common | Class A Common Stock | 2023-03-06 | S | D | 71,916 | $34.40 | 880,078 | D | — | — | (F3) This number represents shares of Class A Common Stock sold to satisfy the tax withholding obligation due upon vesting of LSUs. (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.95 to $34.93, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F2) Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. |
| 5 | Derivative | Leveraged Restricted Stock Unit | 2023-03-03 | M | D | 360,000 | $0.00 | 0 | D | $0.00 · — to — | 360,000 Class A Common Stock | (F7) LSUs vested on March 3, 2023. (F8) These LSUs do not expire. |